Ritholtz Wealth Management Ironwood Pharmaceuticals Inc Transaction History

Ritholtz Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	SELL	$10.1 - $11.6 $1,414 - $1,624	-140 Reduced 0.18%	79,532 $846,000
Q1 2023 Apr 19, 2023	BUY	$10.37 - $12.56 $88,227 - $106,860	8,508 Added 11.96%	79,672 $838,000
Q4 2022 Jan 18, 2023	BUY	$9.9 - $12.43 $224,650 - $282,061	22,692 Added 46.81%	71,164 $0
Q3 2022 Oct 18, 2022	BUY	$10.14 - $12.38 $378,708 - $462,368	37,348 Added 335.74%	48,472 $502,000
Q2 2022 Jul 15, 2022	BUY	$11.05 - $12.72 $122,920 - $141,497	11,124 New	11,124 $128,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $539M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Ritholtz Wealth Management with notifications on news.